Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Povidone Iodine to Reduce Viral Load in COVID-19
NCT04371965Phase 2Completed
- Sponsor
- CHU de Poitiers
- Start
- Sep 2020
- Primary completion
- Oct 2020
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of IVIEW-1502 in coronavirus disease 2019 (COVID-19), sponsored by CHU de Poitiers. Started Sep 2020; status: completed.
02
Drugs
IVIEW-1502
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04371965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04371965.